Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
National Center for Research Resources (NCRR) University of North Carolina |
---|---|
Information provided by: | Office of Rare Diseases (ORD) |
ClinicalTrials.gov Identifier: | NCT00004667 |
OBJECTIVES: I. Evaluate the effect of a new von Willebrand factor concentrate on bleeding time, in vivo recovery, and circulating half-life of the infused factor in patients with von Willebrand's disease. II. Assess the safety of von Willebrand factor in these patients.
Condition | Intervention | Phase |
---|---|---|
Von Willebrand's Disease |
Drug: von Willebrand factor |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Safety/Efficacy Study |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
PROTOCOL ENTRY CRITERIA: - von Willebrand's disease
Study ID Numbers: | 199/11955, UNCCH-826 |
Study First Received: | February 24, 2000 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00004667 History of Changes |
Health Authority: | United States: Federal Government |
hematologic disorders rare disease von Willebrand's disease |
Von Willebrand Disease Thrombocytopathy Hemorrhagic Disorders Genetic Diseases, Inborn Hematologic Diseases |
Blood Platelet Disorders Blood Coagulation Disorders Rare Diseases Hemostatic Disorders |
Von Willebrand Disease Hemorrhagic Disorders Blood Coagulation Disorders, Inherited Genetic Diseases, Inborn |
Coagulation Protein Disorders Hematologic Diseases Blood Platelet Disorders Blood Coagulation Disorders |